MichaelJosephDattoliMD

Radiation Oncology • Sarasota, FL

Urologic Cancer

Physician-in-Chief, Dattoli Cancer Center and Brachytherapy Research Institute, Sarasota, Florida

Join to view full profile

Dr. Dattoli is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dattoli's full profile

Already have an account?

Office
2803 Fruitville Rd
Sarasota, FL 34237
Phone+1 941-957-4926

Fax+1 941-957-0038

Education & Training

Memorial Sloan Kettering Cancer CenterResidency, Radiation Oncology, 1989 - 1990
NYU Grossman School of MedicineResidency, Radiation Oncology, 1986 - 1989
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Internship, Internal Medicine, 1985 - 1986
Icahn School of Medicine at Mount SinaiClass of 1985

Certifications & Licensure

CA State Medical License 1990 - 2026
FL State Medical License 1990 - 2025
NY State Medical License 1990 - 2022
GA State Medical License 1990 - 2003
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

Member, Directors, Prostate Cancer Task Force, Tallahassee Consultant, Washington Oncology Roundtable Advisory Committee
Leading Physicians of the World and Top Brachytherapist 2010-present, Castle-Connolly 2008-present, Patient Compassionate Award 2009-present

Clinical Trials

Palladium-103 Seed Implant and Single Daily Dosing of Uroxatral Vs. Twice Daily Dosing of Flomax- A 3 Month Retrospective Efficacy Analysis Start of enrollment: 2005 Nov 01
Completed

Publications & Presentations

PubMed

3 citations
Replacing LNT: The Integrated LNT-Hormesis Model.
Cara Y Kaminski, Michael J. Dattoli, Joseph M Kaminski
Dose-Response. 2020-04-15
26 citations
Long-Term Outcomes for Patients with Prostate Cancer Having Intermediate and High-Risk Disease, Treated with Combination External Beam Irradiation and Brachytherapy
Michael J. Dattoli, Kent E. Wallner, Lawrence D. True, David Bostwick, Jennifer Cash
Journal of Oncology. 2010-08-18
15 citations
Prostatic Acid Phosphatase Adversely Affects Cause-Specific Survival in Patients with Intermediate to High-Risk Prostate Cancer Treated with Brachytherapy
L. Christine Fang, Michael Dattoli, Al V. Taira, Lawrence D. True, Richard Sorace
Urology. 2008-01-01

Journal Articles

Prostate biopsies using both gray scale and 3D color flow power Doppler ultrasound (3DCFPDU). ASCO-GU, 14100 February 2015
Dattoli,M., Sorace,R., Bostwick, D, JCO, 2/15/2015

Books/Book Chapters

Prostate Brachytherapy Made Complicated,Text Editions 1997,2001,2008
Chapter: Textbooks
Michael Dattoli, MDSmartMedicine Press, Seattle

Press Mentions

The Cost of Raatiodin Oncology-Is It Worth the Investment?April 3rd, 2023
Raatiodin Oncology-a New Era in Cancer TherapyApril 3rd, 2023
The Impact of Raatiodin Oncology on Cancer Clinical TrialsApril 3rd, 2023
Join now to see all

Professional Memberships

ASTRO, ACRO, ABS
Member

Other Languages

Spanish